{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:43:07Z","timestamp":1785595387235,"version":"3.56.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The case report centres on analytical findings from a <jats:italic>spice<\/jats:italic> sample (mixed with tobacco (as a <jats:italic>cigarette<\/jats:italic>) for consumption), and its corresponding plasma sample, smoked by a 31-year-old man who was attended by emergency services following collapse. The man was fully conscious and cooperative during initial medical treatment. Suddenly, he suffered a complete loss of self-control, whereupon the police was notified. The man encountered the police officers when exiting the apartment, at which point he threatened them with clenched fists and reached for a plant bucket in order to strike out in the direction of the officers. At the trial, he described himself as confused and as being completely overwhelmed, having lost self-control, suffered a panic attack and \u201cjust wanted to get out the situation\u201d. Furthermore, he stated that he had no recollection of the incident. He feared death due to palpitations, heart pain, dizziness and repetitive anxiety states. Routine systematic as well as extended toxicological analysis of the plasma sample, taken approximately 2\u00a0h after the incident, confirmed the use of cannabis and <jats:italic>spice<\/jats:italic>. Plasma concentrations of THC, OH-THC and THC-COOH were 8.0\u00a0\u03bcg\/L, 4.0\u00a0\u03bcg\/L and 147\u00a0\u03bcg\/L, respectively. Furthermore, analysis confirmed uptake of 5F-ADB (5F-MDMB-PINACA) via detection of both 5F-ADB and the 5F-ADB <jats:italic>N<\/jats:italic>-(5-OH-pentyl) metabolite. The <jats:italic>spice<\/jats:italic> sample additionally contained 5F-MDMB-PICA, which was not detected in the plasma sample. A differentiation between a possible co-use and a recent use of cannabis was not possible. In summary, this case once more underlines the health risks of <jats:italic>spice<\/jats:italic> use.<\/jats:p>","DOI":"10.1007\/s00414-021-02717-6","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T03:07:41Z","timestamp":1639796861000},"page":"577-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report"],"prefix":"10.1007","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9759-3161","authenticated-orcid":false,"given":"Franziska","family":"Gaunitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-8902","authenticated-orcid":false,"given":"Hilke","family":"Andresen-Streichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"key":"2717_CR1","unstructured":"EMCDDA (2019) Europ\u00e4ischer Drogenbericht 2019 - Trends und Entwicklungen (in German). European Drug Report 2019 - Trends and developments. European Monitoring Centre for Drugs und Drug Addiction, Luxembourg"},{"key":"2717_CR2","doi-asserted-by":"crossref","unstructured":"Fattore L, Fratta W (2011) Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 5(60):12","DOI":"10.3389\/fnbeh.2011.00060"},{"issue":"1\u20132","key":"2717_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.drugalcdep.2012.12.011","volume":"131","author":"AR Winstock","year":"2013","unstructured":"Winstock AR, Barratt MJ (2013) Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend 131(1\u20132):106\u2013111","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2717_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/08897077.2013.846288","volume":"35","author":"EW Gunderson","year":"2014","unstructured":"Gunderson EW et al (2014) A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus 35(2):184\u2013189","journal-title":"Subst Abus"},{"key":"2717_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainresbull.2016.04.013","volume":"126","author":"G Loeffler","year":"2016","unstructured":"Loeffler G, Delaney E, Hann M (2016) International trends in spice use: prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids. Brain Res Bull 126:8\u201328","journal-title":"Brain Res Bull"},{"key":"2717_CR6","doi-asserted-by":"crossref","unstructured":"Moosmann B, Auw\u00e4rter V (2017) Pharmakologie und Toxikologie synthetischer Cannabinoidrezeptor-Agonisten (in German), in Handbuch Psychoaktive Substanzen. Springer Verlag GmbH, Berlin, p. 389\u2013410","DOI":"10.1007\/978-3-642-55125-3_61"},{"issue":"Suppl. 1","key":"2717_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","volume":"20","author":"K Mackie","year":"2008","unstructured":"Mackie K (2008) Cannabinoid receptors: where they are and what they do. J Neuroendocrinol 20(Suppl. 1):10\u201314","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"2717_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40429-014-0014-y","volume":"1","author":"S Tai","year":"2014","unstructured":"Tai S, Fantegrossi WE (2014) Synthetic cannabinoids: pharmacology, behavioral effects, and abuse potential. Curr Addict Rep 1(2):129\u2013136","journal-title":"Curr Addict Rep"},{"key":"2717_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00194-012-0810-4","volume":"22","author":"V Auw\u00e4rter","year":"2012","unstructured":"Auw\u00e4rter V et al (2012) Synthetische Cannabinoide: Forensische Relevanz und interpretation analytischer Befunde (in German). Rechtsmedizin 22:259\u2013271","journal-title":"Rechtsmedizin"},{"issue":"9","key":"2717_CR10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1021\/acschemneuro.5b00112","volume":"6","author":"SD Banister","year":"2015","unstructured":"Banister SD et al (2015) The pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA and 5F-ADBICA. ACS Chem Neurosci 6(9):1546\u20131559","journal-title":"ACS Chem Neurosci"},{"key":"2717_CR11","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1021\/acschemneuro.6b00137","volume":"7","author":"SD Banister","year":"2016","unstructured":"Banister SD et al (2016) Pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues. ACS Chem Neurosci 7:1241\u20131254","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"2717_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11419-018-0415-z","volume":"36","author":"CT Schoeder","year":"2018","unstructured":"Schoeder CT et al (2018) Pharmacological evaluation of new constituents of \u201cspice\u201d: synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds. Forensic Toxicol 36(2):385\u2013403","journal-title":"Forensic Toxicol"},{"key":"2717_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11419-016-0320-2","volume":"34","author":"C Hess","year":"2016","unstructured":"Hess C et al (2016) Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol 34:329\u2013343","journal-title":"Forensic Toxicol"},{"key":"2717_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.forsciint.2019.02.021","volume":"298","author":"M Kraemer","year":"2019","unstructured":"Kraemer M et al (2019) Death cases involving certain new psychoactive substances: a review of the literature. Forensic Sci Int 298:186\u2013267","journal-title":"Forensic Sci Int"},{"key":"2717_CR15","doi-asserted-by":"crossref","unstructured":"Hermanns-Clausen M et al (2016) Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project. Drug Test Anal\u00a08(10):1030\u20131038","DOI":"10.1002\/dta.1936"},{"issue":"3","key":"2717_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","volume":"108","author":"M Hermanns-Clausen","year":"2012","unstructured":"Hermanns-Clausen M et al (2012) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 108(3):534\u2013544","journal-title":"Addiction"},{"issue":"6","key":"2717_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/15563650.2017.1393082","volume":"56","author":"M Hermanns-Clausen","year":"2018","unstructured":"Hermanns-Clausen M et al (2018) Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clin Toxicol 56(6):404\u2013411","journal-title":"Clin Toxicol"},{"key":"2717_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa1610300","volume":"376","author":"AJ Adams","year":"2017","unstructured":"Adams AJ et al (2017) \u201cZombie\u201d outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York. N Engl J Med 376:235\u2013242","journal-title":"N Engl J Med"},{"key":"2717_CR19","unstructured":"Angerer V et al (2016) Comprehensive characterization of the synthetic cannabinoid NE-CHMIMO within an intoxication case. TIAFT, Brisbane"},{"key":"2717_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/jat\/bkw004","volume":"40","author":"V Angerer","year":"2016","unstructured":"Angerer V et al (2016) Letter to the editor. Reply to \u2018sudden cardiac death following use of the synthetic cannabinoid MDMB-CHMICA\u2019. J Anal Toxicol 40:240\u2013242","journal-title":"J Anal Toxicol"},{"key":"2717_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s13181-016-0584-2","volume":"13","author":"M B\u00e4ckberg","year":"2017","unstructured":"B\u00e4ckberg M et al (2017) Analytically confirmed intoxications involving MDMB-CHMICA from the STRIDA project. Journal of Medical Toxicology 13:52\u201360","journal-title":"Journal of Medical Toxicology"},{"key":"2717_CR22","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.forsciint.2017.01.020","volume":"273","author":"B Barcel\u00f3","year":"2017","unstructured":"Barcel\u00f3 B et al (2017) Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: a case series. Forensic Sci Int 273:e10\u2013e14","journal-title":"Forensic Sci Int"},{"issue":"8","key":"2717_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/jat\/bku048","volume":"38","author":"G Behonick","year":"2014","unstructured":"Behonick G et al (2014) Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. J Anal Toxicol 38(8):559\u2013562","journal-title":"J Anal Toxicol"},{"issue":"1","key":"2717_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5409\/wjcp.v5.i1.16","volume":"5","author":"D Castellanos","year":"2016","unstructured":"Castellanos D, Gralnik LM (2016) Synthetic cannabinoids 2015: an update for pediatricians in clinical practice. World J Clin Pediatr 5(1):16\u201324","journal-title":"World J Clin Pediatr"},{"issue":"3","key":"2717_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12024-015-9669-5","volume":"11","author":"D Gerostamoulos","year":"2015","unstructured":"Gerostamoulos D, Drummer OH, Woodford NW (2015) Deaths linked to synthetic cannabinoids. Forensic Sci Med Pathol 11(3):478","journal-title":"Forensic Sci Med Pathol"},{"issue":"2","key":"2717_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/10826084.2016.1223692","volume":"52","author":"M Haden","year":"2017","unstructured":"Haden M et al (2017) MDMB-CHMICA: availability, patterns of use, and toxicity associated with this novel psychoactive substance. Subst Use Misuse 52(2):223\u2013232","journal-title":"Subst Use Misuse"},{"issue":"2","key":"2717_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jemermed.2012.07.061","volume":"44","author":"CR Harris","year":"2013","unstructured":"Harris CR, Brown A (2013) Synthetic cannabinoid intoxication: a case series and review. J Emerg Med 44(2):360\u2013366","journal-title":"J Emerg Med"},{"key":"2717_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11419-014-0245-6","volume":"33","author":"K Hasegawa","year":"2015","unstructured":"Hasegawa K et al (2015) Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol 33:45\u201353","journal-title":"Forensic Toxicol"},{"key":"2717_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11419-014-0259-0","volume":"33","author":"K Hasegawa","year":"2015","unstructured":"Hasegawa K et al (2015) Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products. Forensic Toxicol 33:112\u2013121","journal-title":"Forensic Toxicol"},{"key":"2717_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11419-015-0272-y","volume":"33","author":"K Hasegawa","year":"2015","unstructured":"Hasegawa K et al (2015) Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver. Forensic Toxicol 33:380\u2013387","journal-title":"Forensic Toxicol"},{"key":"2717_CR31","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.forsciint.2015.08.012","volume":"257","author":"C Hess","year":"2015","unstructured":"Hess C et al (2015) Death due to diabetic ketoacidosis: induction by the consumption of synthetic cannabinoids? Forensic Sci Int 257:e6\u2013e11","journal-title":"Forensic Sci Int"},{"issue":"8","key":"2717_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1080\/15563650.2016.1190980","volume":"54","author":"SL Hill","year":"2016","unstructured":"Hill SL et al (2016) Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the identification of novel psychoActive substances (IONA) study. Clin Toxicol 54(8):638\u2013643","journal-title":"Clin Toxicol"},{"issue":"8","key":"2717_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/jat\/bkt068","volume":"37","author":"R Kronstrand","year":"2013","unstructured":"Kronstrand R et al (2013) Toxicological findings of synthetic cannabinoids in recreational users. J Anal Toxicol 37(8):534\u2013541","journal-title":"J Anal Toxicol"},{"key":"2717_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.forsciint.2015.12.046","volume":"260","author":"LM Labay","year":"2016","unstructured":"Labay LM et al (2016) Synthetic cannabinoid drug use as a cause or contributory cause of death. Forensic Sci Int 260:31\u201339","journal-title":"Forensic Sci Int"},{"issue":"3","key":"2717_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jemermed.2010.10.014","volume":"40","author":"AB Schneir","year":"2011","unstructured":"Schneir AB, Cullen J, Ly BT (2011) \u201cSpice\u201d girls: synthetic cannabinoid intoxication. J Emerg Med 40(3):296\u2013299","journal-title":"J Emerg Med"},{"issue":"5","key":"2717_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jemermed.2014.12.038","volume":"48","author":"MD Schwartz","year":"2015","unstructured":"Schwartz MD et al (2015) A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA. J Emerg Med 48(5):573\u2013580","journal-title":"J Emerg Med"},{"issue":"1","key":"2717_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","volume":"54","author":"RJ Tait","year":"2016","unstructured":"Tait RJ et al (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol 54(1):1\u201313","journal-title":"Clin Toxicol"},{"issue":"3","key":"2717_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/08897077.2016.1219438","volume":"38","author":"J Tournebize","year":"2017","unstructured":"Tournebize J, Gibaja V, Kahn J-P (2017) Acute effects of synthetic cannabinoids: update 2015. Subst Abus 38(3):344\u2013366","journal-title":"Subst Abus"},{"issue":"2","key":"2717_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJMp1505328","volume":"373","author":"J Trecki","year":"2015","unstructured":"Trecki J, Gerona RR, Schwartz MD (2015) Synthetic cannabinoid\u2013related illnesses and deaths. N Engl J Med 373(2):103\u2013107","journal-title":"N Engl J Med"},{"issue":"10","key":"2717_CR40","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3109\/15563650.2015.1100306","volume":"53","author":"JA Tyndall","year":"2015","unstructured":"Tyndall JA et al (2015) An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA. Clin Toxicol 53(10):950\u2013956","journal-title":"Clin Toxicol"},{"key":"2717_CR41","unstructured":"WEDINOS (2015) Alert: hospitalisation from synthetic cannabinoid MMB-CHMINACA, in http:\/\/asfa.cymru\/wp-content\/uploads\/2015\/07\/MMB-CHMINACA-MDMB-CHMICA-alert.pdf. WEDINOS. Accessed\u00a010 Oct 2019"},{"issue":"1","key":"2717_CR42","first-page":"86","volume":"40","author":"AA Westin","year":"2015","unstructured":"Westin AA et al (2015) Sudden cardiac death following use of the synthetic cannabinoid MDMB-CHMICA. J Anal Toxicol 40(1):86\u201387","journal-title":"J Anal Toxicol"},{"issue":"6","key":"2717_CR43","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/0269881115574493","volume":"29","author":"A Winstock","year":"2015","unstructured":"Winstock A et al (2015) Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. J Psychopharmacol 29(6):698\u2013703","journal-title":"J Psychopharmacol"},{"issue":"27","key":"2717_CR44","first-page":"464","volume":"106","author":"US Zimmermann","year":"2009","unstructured":"Zimmermann US et al (2009) Withdrawal phenomena and dependence syndrome after the consumption of \u201cspice gold\u201d. Dtsch Arztebl Int 106(27):464\u2013467","journal-title":"Dtsch Arztebl Int"},{"key":"2717_CR45","unstructured":"Gurney SMR et al (2014) Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev\u00a026(1):53\u201378"},{"key":"2717_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hup.2312","volume":"28","author":"D Papanti","year":"2013","unstructured":"Papanti D et al (2013) \u201cSpiceophrenia\u201d: a systematic overview of \u201cspice\u201d-related psychopathological issues and a case report. Hum Psychopharmacol Clin Exp 28:379\u2013389","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"6","key":"2717_CR47","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/1556-4029.12216","volume":"58","author":"AL Patton","year":"2013","unstructured":"Patton AL et al (2013) K2 toxicity: fatal case of psychiatric complications following AM-2201 exposure. J Forensic Sci 58(6):1676\u20131680","journal-title":"J Forensic Sci"},{"key":"2717_CR48","first-page":"248","volume":"80","author":"N Schaefer","year":"2013","unstructured":"Schaefer N et al (2013) A fatal case involving several synthetic cannabinoids. Toxichem Krimtech 80:248\u2013251","journal-title":"Toxichem Krimtech"},{"key":"2717_CR49","unstructured":"EMCDDA (2018) Europ\u00e4ischer Drogenbericht 2018 - Trends und Entwicklungen (in German). European drug report 2018 - trends and developments. European Monitoring Centre for Drugs und Drug Addiction, Luxembourg"},{"issue":"4","key":"2717_CR50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1055\/s-0029-1243252","volume":"43","author":"H Muller","year":"2010","unstructured":"Muller H et al (2010) Panic attack after spice abuse in a patient with ADHD. Pharmacopsychiatry 43(4):152\u2013153","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"2717_CR51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1373\/clinchem.2017.275867","volume":"64","author":"SL Hill","year":"2018","unstructured":"Hill SL et al (2018) Human toxicity caused by indole and indazole carboxylate synthetic cannabinoid receptor agonists: from horizon scanning to notification. Clin Chem 64(2):346","journal-title":"Clin Chem"},{"key":"2717_CR52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.forsciint.2019.02.005","volume":"297","author":"ID Ivanov","year":"2019","unstructured":"Ivanov ID et al (2019) A case of 5F-ADB \/ FUB-AMB abuse: drug-induced or drug-related death? Forensic Sci Int 297:372\u2013377","journal-title":"Forensic Sci Int"},{"issue":"2","key":"2717_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/dta.2215","volume":"10","author":"M Kusano","year":"2018","unstructured":"Kusano M et al (2018) Fatal intoxication by 5F-ADB and diphenidine: detection, quantification, and investigation of their main metabolic pathways in humans by LC\/MS\/MS and LC\/Q-TOFMS. Drug Test Anal 10(2):284\u2013293","journal-title":"Drug Test Anal"},{"issue":"2","key":"2717_CR54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","volume":"39","author":"KA Seely","year":"2012","unstructured":"Seely KA et al (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuro-Psychopharmacol Biol Psychiatry 39(2):234\u2013243","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2717_CR55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fpubh.2018.00162","volume":"6","author":"K Cohen","year":"2018","unstructured":"Cohen K, Weinstein AM (2018) Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective. Front Public Health 6:162\u2013162","journal-title":"Front Public Health"},{"issue":"3","key":"2717_CR56","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0269881119826592","volume":"33","author":"H Akram","year":"2019","unstructured":"Akram H, Mokrysz C, Curran HV (2019) What are the psychological effects of using synthetic cannabinoids? A systematic review. J Psychopharmacol 33(3):271\u2013283","journal-title":"J Psychopharmacol"},{"key":"2717_CR57","unstructured":"EMCCDA\/Europol (2017) Europol joint report - 5F-MDMB-PINACA. European monitoring Centre for drugs and drug addiction. Europol, Luxembourg"},{"issue":"2","key":"2717_CR58","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s11419-017-0369-6","volume":"35","author":"S Kaneko","year":"2017","unstructured":"Kaneko S (2017) Motor vehicle collisions caused by the \u2018super-strength\u2019 synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014. Forensic Toxicol 35(2):244\u2013251","journal-title":"Forensic Toxicol"},{"key":"2717_CR59","unstructured":"WHO (2017) Critical review report - 5F-ADB. World Health Organization, Geneva"},{"key":"2717_CR60","unstructured":"UNODC (2018) News: August 2018 \u2013 China: China places additional 32 new psychoactive substances under national control. United Nations Office on Drugs and Crime.\u00a0unodc.org.\u00a0Accessed 29 Aug 2020"},{"key":"2717_CR61","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fchem.2019.00321","volume":"7","author":"LH Antonides","year":"2019","unstructured":"Antonides LH et al (2019) Enantiospecific synthesis, chiral separation, and biological activity of four indazole-3-carboxamide-type synthetic cannabinoid receptor agonists and their detection in seized drug samples. Front Chem 7:321\u2013321","journal-title":"Front Chem"},{"issue":"6","key":"2717_CR62","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2131\/jts.41.813","volume":"41","author":"N Asaoka","year":"2016","unstructured":"Asaoka N et al (2016) A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neurons. J Toxicol Sci 41(6):813\u2013816","journal-title":"J Toxicol Sci"},{"key":"2717_CR63","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.forsciint.2019.05.017","volume":"301","author":"M Kraemer","year":"2019","unstructured":"Kraemer M et al (2019) Mono\u2212\/polyintoxication with 5F-ADB: a case series. Forensic Sci Int 301:e29\u2013e37","journal-title":"Forensic Sci Int"},{"issue":"2","key":"2717_CR64","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/jat\/bkx088","volume":"42","author":"K Usui","year":"2017","unstructured":"Usui K et al (2017) Identification of 5-Fluoro ADB in human whole blood in four death cases. J Anal Toxicol 42(2):e21\u2013e25","journal-title":"J Anal Toxicol"},{"issue":"2","key":"2717_CR65","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11419-017-0354-0","volume":"35","author":"K Minakata","year":"2017","unstructured":"Minakata K et al (2017) Sensitive identification and quantitation of parent forms of six synthetic cannabinoids in urine samples of human cadavers by liquid chromatography\u2013tandem mass spectrometry. Forensic Toxicol 35(2):275\u2013283","journal-title":"Forensic Toxicol"},{"key":"2717_CR66","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.forsciint.2017.10.042","volume":"281","author":"V Angerer","year":"2017","unstructured":"Angerer V et al (2017) Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA. Forensic Sci Int 281:e9\u2013e15","journal-title":"Forensic Sci Int"},{"key":"2717_CR67","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/dta.2786","volume":"12","author":"S Halter","year":"2020","unstructured":"Halter S et al (2020) Impact of legislation on NPS markets in Germany - the rise and fall of 5F-ADB. Drug Test Anal 12:854\u2013856","journal-title":"Drug Test Anal"},{"issue":"6","key":"2717_CR68","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/dta.2566","volume":"11","author":"O Yeter","year":"2019","unstructured":"Yeter O, Ozturk YE (2019) Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry. Drug Test Anal 11(6):847\u2013858","journal-title":"Drug Test Anal"},{"issue":"22","key":"2717_CR69","doi-asserted-by":"publisher","first-page":"e8908","DOI":"10.1002\/rcm.8908","volume":"34","author":"BC Presley","year":"2020","unstructured":"Presley BC et al (2020) Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography\/high-resolution mass spectrometry. Rapid Commun Mass Spectrom 34(22):e8908","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"2","key":"2717_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11419-017-0355-z","volume":"35","author":"F Gaunitz","year":"2017","unstructured":"Gaunitz F et al (2017) Analysis of taxine B\/isotaxine B in a plasma specimen by LC\u2013MS\/MS in a case of fatal poisoning: concealed suicide by ingestion of yew (Taxus L.) leaves of a patient with a long-term history of borderline personality disorder. Forensic Toxicol 35(2):421\u2013427","journal-title":"Forensic Toxicol"},{"issue":"2","key":"2717_CR71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/dta.2490","volume":"11","author":"T Kieliba","year":"2019","unstructured":"Kieliba T et al (2019) Simultaneous quantification of THC-COOH, OH-THC, and further cannabinoids in human hair by gas chromatography\u2013tandem mass spectrometry with electron ionization applying automated sample preparation. Drug Test Anal 11(2):267\u2013278","journal-title":"Drug Test Anal"},{"key":"2717_CR72","doi-asserted-by":"crossref","unstructured":"Gaunitz F et al (2020) Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine. Drug Test Anal\u00a012(1):27\u201340","DOI":"10.1002\/dta.2680"},{"key":"2717_CR73","unstructured":"Toennes SW (2012) M\u00f6glichkeiten und Grenzen der Interpretation von Cannabinoid-Blutkonzentrationen (in German). Blutalkohol 49: p. Sup II-51 - Sup II-52"},{"key":"2717_CR74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/dta.1581","volume":"6","author":"M Fabritius","year":"2014","unstructured":"Fabritius M et al (2014) THC-COOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers? Drug Test Anal 6:155\u2013163","journal-title":"Drug Test Anal"},{"key":"2717_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.05.014","volume":"242","author":"M Fabritius","year":"2014","unstructured":"Fabritius M et al (2014) Fitness to drive and cannabis: validation of two blood THC-COOH thresholds to distinguish occasional users from heavy smokers. Forensic Sci Int 242:1\u20138","journal-title":"Forensic Sci Int"},{"issue":"11","key":"2717_CR76","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/jcph.1512","volume":"59","author":"M Lutz","year":"2019","unstructured":"Lutz M (2019) Metamizole (dipyrone) and the liver: a review of the literature. J Clin Pharmacol 59(11):1433\u20131442","journal-title":"J Clin Pharmacol"},{"key":"2717_CR77","doi-asserted-by":"crossref","unstructured":"Schulz M et al (2020) Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care 24(195)","DOI":"10.1186\/s13054-020-02915-5"}],"updated-by":[{"DOI":"10.1007\/s00414-022-02894-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000}}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-021-02717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00414-021-02717-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-021-02717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T14:15:48Z","timestamp":1666361748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00414-021-02717-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,18]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2717"],"URL":"https:\/\/doi.org\/10.1007\/s00414-021-02717-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00414-022-02894-y","asserted-by":"object"}]},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"value":"0937-9827","type":"print"},{"value":"1437-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,18]]},"assertion":[{"value":"11 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00414-022-02894-y","URL":"https:\/\/doi.org\/10.1007\/s00414-022-02894-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All conducted experiments comply with the current laws of the Federal Republic of Germany. This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The competent public prosecutor\u2019s office in Cologne gave permission for the publication of this case.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}